Streamline Health Solutions (STRM) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Streamline Health Solutions in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" STRM shares.
View STRM analyst ratings or view top-rated stocks.

1 brokerages have issued 1 year price targets for Streamline Health Solutions' shares. Their STRM share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 93.5% from the stock's current price.
View analysts price targets for STRM or view top-rated stocks among Wall Street analysts.

Streamline Health Solutions' stock was trading at $1.58 at the beginning of 2023. Since then, STRM stock has decreased by 1.9% and is now trading at $1.55.
View the best growth stocks for 2023 here.

Streamline Health Solutions saw a drop in short interest in May. As of May 15th, there was short interest totaling 14,100 shares, a drop of 65.2% from the April 30th total of 40,500 shares. Based on an average daily volume of 41,800 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.0% of the shares of the company are short sold.
View Streamline Health Solutions' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 14th 2023.
View our STRM earnings forecast.

Streamline Health Solutions, Inc. (NASDAQ:STRM) released its quarterly earnings data on Wednesday, April, 27th. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.06). The company had revenue of $6.05 million for the quarter. Streamline Health Solutions had a negative net margin of 45.72% and a negative trailing twelve-month return on equity of 35.11%. During the same period last year, the company posted ($0.05) earnings per share.

31 employees have rated Streamline Health Solutions Chief Executive Officer David Sides on Glassdoor.com. David Sides has an approval rating of 82% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Streamline Health Solutions investors own include Energy Transfer (ET), CBL & Associates Properties (CBL), Garrison Capital (GARS), SandRidge Permian Trust (PER), BIOLASE (BIOL), Inovio Pharmaceuticals (INO), Martin Midstream Partners (MMLP), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX) and Aeterna Zentaris (AEZS).

Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."

Streamline Health Solutions' stock is owned by many different institutional and retail investors. Top institutional investors include Punch & Associates Investment Management Inc. (2.47%), BlackRock Inc. (0.73%), Geode Capital Management LLC (0.62%), UBS Group AG (0.58%), Renaissance Technologies LLC (0.48%) and Boothbay Fund Management LLC (0.32%). Insiders that own company stock include Global Healthcare Fun Tamarack and Kenan Lucas.
View institutional ownership trends.

Shares of STRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STRM stock can currently be purchased for approximately $1.55.

Streamline Health Solutions (NASDAQ:STRM) has a market capitalization of $90.85 million and generates $24.89 million in revenue each year. The company earns $-11,380,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis.

Streamline Health Solutions' mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The official website for the company is www.streamlinehealth.net. The company can be reached via phone at (888) 997-8732 or via email at randy.salisbury@streamlinehealth.net.